Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
NCT01882855 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2016-03-11
Summary
Hepatic encephalopathy (HE) is a potentially reversible, metabolically caused complication of acute or chronic liver diseases such as cirrhosis. Due to the diseased liver's inability to remove toxins such as ammonia, which is produced in the gastrointestinal tract, the ammonia accumulates in the brain and causes forgetfulness, confusion, disorientation, concentration and memory problems, changes in mood, decreased alertness and responsiveness, changes in sleep habits, muscle tremors and stiffness, speech impairments, uncontrollable movements, agitation.
This study will examine music as a possible external factor that could contribute to impairment in attention and progressive memory in cirrhotic patients while driving. Sustaining attention is important for learning and remembering new information, for e.g. keeping the car within lane and paying attention to cyclists and pedestrians. Prospective memory is the ability to remember to perform previously intended tasks at the appropriate time or occasion, for instance remembering the correct exit while driving on the highway. Impairment in any of these areas may result in serious consequences for patient with cirrhosis. There is evidence that some subsets of cirrhotic patients have a diminished ability to drive and significantly more motor vehicle crashes and traffic violations. In these patients, listening to music while driving may further jeopardize their driving ability, which in turn may lead to reduced quality of life and increased medical costs (from motor vehicle accidents).
This is a cross-sectional study designed to determine if there is any effect of listening to music on attention and prospective memory in patients with cirrhosis. For these purposes, subjects will be asked to come for one study visit, which will last approximately 2 hours. During this visit, subjects will undergo a series of screening procedures (consent, assignment of subject identification number, demographics, medical history, physical examination, vitals, height, weight, and eligibility assessment). If they are found eligible, subjects will undergo several neuropsychological assessments to measure any effect of music on attention and prospective memory. These assessments include including Number Connection Test (NCT), Digit Symbol Test (DST), Cambridge Prospective Memory Test (CAMPROMPT) and Inhibitory Control Test (ICT).
Conditions
- Cirrhosis
- Hepatic Encephalopathy
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Samuel Sigal, MD · NYU Langone Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2016-03-31
- Completion
- 2016-03-31
Countries
- United States
Study Locations
More Related Trials
-
Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement
NCT06052176 ·Status: RECRUITING ·Phase: PHASE2
-
Cerebral Oxygen, Blood Flow and Ammonia Uptake in Patients With Cirrhosis and an Acute Episode of Hepatic Encephalopathy (HE)
NCT01151475 ·Status: COMPLETED
-
Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital
NCT06953921 ·Status: RECRUITING
-
FMT in Cirrhosis and Hepatic Encephalopathy
NCT03796598 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Metobolomics in the Characterisation of HE
NCT06245473 ·Status: COMPLETED
-
Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis
NCT02335580 ·Status: COMPLETED
-
Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy
NCT04096014 ·Status: RECRUITING ·Phase: NA
-
EYE-Mobile TRACKer IN the Diagnosis of Minimal Hepatic Encephalopathy
NCT03732118 ·Status: UNKNOWN
-
Liver Transplant Does it Affect the Brain
NCT04368052 ·Status: COMPLETED ·Phase: NA
-
Plasma Free Amino Acids in Patients With Hepatic Encephalopathy
NCT03306498 ·Status: UNKNOWN
-
HEAL STUDY (Hepatic Encephalopathy and Albumin Study)
NCT03585257 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal Hypertension
NCT04807803 ·Status: COMPLETED ·Phase: NA
-
Characterization of Metabolomic Fingerprints in Patients With Acute Liver Failure and Acute-on-chronic Liver Failure With Hepatic Encephalopathy
NCT05772585 ·Status: WITHDRAWN
-
The Influence of Nutritional Factors on the Prognosis of Liver Cirrhosis Patients and the Exploration of Predictive Models
NCT06328517 ·Status: RECRUITING
-
The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy.
NCT04675775 ·Status: COMPLETED ·Phase: NA
-
Mindfulness and Support Group to Improve Patient and Caregiver Burden in Cirrhosis
NCT02944643 ·Status: COMPLETED ·Phase: NA
-
Acetyl-L-Carnitine In Severe Hepatic Encephalopathy
NCT01223768 ·Status: COMPLETED ·Phase: NA
-
Effects of Proteins in Patients With Cirrhosis and Prior Hepatic Encephalopathy
NCT00955500 ·Status: COMPLETED ·Phase: PHASE4
-
Polyethylene Glycol Versus Lactulose on Hepatic Encephalopathy in Patients With Cirrhosis;(PEGHE Trial)
NCT04436601 ·Status: UNKNOWN ·Phase: PHASE4
-
A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study]
NCT02377947 ·Status: COMPLETED
-
Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
NCT02026609 ·Status: TERMINATED
-
Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy
NCT01223729 ·Status: COMPLETED ·Phase: NA
-
Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
NCT04073290 ·Status: RECRUITING ·Phase: PHASE4
-
Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
NCT01923376 ·Status: WITHDRAWN ·Phase: NA
-
Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis- Assessment of Impact on Prognosis and Short-term Outcome
NCT03827772 ·Status: UNKNOWN ·Phase: NA